Moreover, cells that suppress the immune system from recognizing tumors, such as myeloid-derived suppressor cells (MDSCs), were reduced by more than 40% in the combination with the PS-targeting antibody versus anti-PD-1 alone.
How many Billions are the Germany based backers of Oncologie ready to spend? Lots of manufacturing rights coming for Avid CDMO